Increasing frequency beyond the weekly schedule risks unpredictable drug accumulation, injection site irritation, nausea or other GI side effects from inappropriate dosing intervals, and data gapsthis dosing pattern hasn't been studied in clinical trials
Pregnant women or those planning to become pregnant should also exercise caution, as the effects of tirzepatide on pregnancy are not well studied
Then Lilly killed the bimagrumab trial in patients with Type 2 diabetes
For patients with known diabetic retinopathy, ensure timely retinal evaluation and follow-up within a few months after starting GLP-1 medications, especially during rapid HbA1c improvement, he said
Is it as good as the injection
The cytoprotective effects of GLP-1(2836) are attenuated in the absence of sAC